natgillin/translations-raw huggingface dataset:
Because calcitonin is a peptide, the possibility of systemic allergic reactions exists and allergic-type reactions including isolated cases of anaphylactic shock have been reported in patients receiving calcitonin.
Ker je kalcitonin peptid, obstaja možnost sistemskih alergijskih reakcij; poročali so o reakcijah alergijskega tipa pri bolnikih, ki so prejemali kalcitonin, s posameznimi primeri anafilaktičnega šoka.
Salmon calcitonin is a hormone which increases the amount of calcium and phosphate laid down in the bones and lowers the level of calcium circulating in the blood.
Lososov kalcitonin je hormon, ki zvišuje količino kalcija in fosfata v kosteh in znižuje raven kalcija v krvi.
Calcitonin receptor down-regulation may also result in a reduced clinical response in a small percentage of patients following long-term therapy.
Tudi zmanjševanje števila receptorjev za kalcitonin na tarčni celici (»down-regulation«) lahko pri majhnem odstotku bolnikov po dolgoročnem zdravljenju povzroči zmanjšan klinični odziv.
FORCALTONIN is used to prevent loss of bone if you are suddenly immobilised, for example, after having a fracture due to osteoporosis.
FORCALTONIN preprečuje izgubljanje kostnine, če postanete nepričakovano nepokretni, na primer po zlomu zaradi osteoporoze.
Frequency categories:
Navedba pogostnosti:
Nausea, vomiting, flushing and dizziness are known to be dose dependent when calcitonin is administered parenterally.
Znano je, da so slabost, bruhanje in omotičnost odvisni od odmerka pri parenteralnem dajanju kalcitonina.
Storing FORCALTONIN
SHRANJEVANJE FORCALTONINA
The recommended starting dose is 100 IU every 6 to 8 hours by subcutaneous or intramuscular injection.
Priporočeni začetni odmerek je 100 IE na vsakih 6 do 8 ur s subkutanim ali intramuskularnim injiciranjem.
If you have any questions about the length of your treatment, ask your doctor or nurse.
Če imate vprašanja o trajanju zdravljenja, vprašajte svojega zdravnika ali medicinsko sestro.
Use of FORCALTONIN in children: It is not recommended to use FORCALTONIN in children.
Uporaba FORCALTONINA pri otrocih: Uporabo FORCALTONINA pri otrocih odsvetujemo.
Please tell your doctor if you are receiving treatment for a heart complaint, because the dose of the heart drug may need to be adjusted.
Če vas zdravijo zaradi težav s srcem, seznanite s tem svojega zdravnika, ker bo treba morda ustrezno spremeniti odmerek vašega zdravila za srce.
In lactating animals given calcitonin, suppression of milk production has been observed.
Pri doječih živalih, ki so prejemale kalcitonin, se je bilo zmanjšalo nastajanje mleka.
Uncommon: diarrhea
Občasni: diareja
MANUFACTURER'S BATCH NUMBER <Batch> <Lot> <BN>{number}
IZDELOVALČEVA ŠTEVILKA SERIJE IZDELAVE ZDRAVILA <Serija> <Lot> <BN> {številka}
Decreases in bone resorption as judged by a reduction in urinary hydroxyproline and deoxypyridinoline are observed following calcitonin treatment in both normal volunteers and patients with bone-related disorders, including Paget's disease and osteoporosis.
Zmanjšano resorpcijo kosti, ocenjeno na podlagi zmanjšanja hidroksiprolina in dezoksipiridinolina v urinu, so opazili po zdravljenju s kalcitoninom tako pri zdravih prostovoljcih kot pri bolnikih z boleznimi kosti, vključno s Pagetovo boleznijo in osteoporozo.
Salmon calcitonin may be administered at bedtime to reduce the incidence of nausea or vomiting which may occur, especially at the initiation of therapy.
Lososov kalcitonin lahko dajemo pred spanjem, da zmanjšamo pogostnost slabosti ali bruhanja, ki se lahko pojavi, zlasti na začetku zdravljenja.
You should tell your doctor if you are taking other calcium lowering drugs, such as bisphosphonates, as the combination of these drugs with FORCALTONIN might cause the amount of calcium in your blood to become too low.
Če jemljete druga zdravila za zniževanje kalcija, na primer biofosfonate, povejte svojemu zdravniku; jemanje teh zdravil skupaj s FORCALTONINom lahko povzroči, da se preveč zniža količina kalcija v krvi.
Patients must therefore be warned that transient dizziness may occur, in which case they should not drive or use machines.”
Bolnike moramo zato opozoriti, da se lahko pojavi prehodna omotičnost in da v tem primeru ne smejo voziti ali upravljati strojev
Calcitonin markedly reduces bone turnover in conditions with an increased rate of bone resorption such as Paget ‘s disease and acute bone loss due to sudden immobilisation.
Kalcitonin opazno zmanjšuje kostno presnovo pri bolezenskih stanjih s povečano hitrostjo resorpcije kosti, na primer pri Pagetovi bolezni in akutnem izgubljanju kostnine zaradi nenadne nepokretnosti.
Animal studies have shown that calcitonin is primarily metabolised via proteolysis in the kidney following parenteral administration.
Študije na živalih so pokazale, da se kalcitonin po parenteralnem dajanju primarno presnavlja s proteolizo v ledvicah.
This undesirable effect occurs mostly at the beginning of treatment and tends to decrease or even disappear as treatment continues.
Ta neželeni učinek se navadno pojavi na začetku zdravljenja, z nadaljevanjem zdravljenja pa običajno izgine ali se zmanjša.
QUALITATIVE AND QUANTITATIVE COMPOSITION One ampoule of Forcaltonin 100 IU contains 100 International Units (IU) corresponding to approximately 15 micrograms recombinant salmon calcitonin (produced by recombinant DNA technology in Escherichia coli) in 1 ml of an acetate buffer.
KAKOVOSTNA IN KOLIČINSKA SESTAVA Ena ampula Forcaltonina 100 IE vsebuje 100 mednarodnih enot (IE), kar ustreza približno 15 mikrogramom rekombinantnega lososovega kalcitonina (proizveden z rekombinantno DNK tehnologijo v Escherichia coli) v 1 ml acetatnega pufra.
However, the structure of the active substance of FORCALTONIN is the same as that of chemically synthesised salmon calcitonin.
Vendar pa je struktura zdravilne učinkovine v FORCALTONINu enaka kot pri kemijsko sintetiziranem lososovem kalcitoninu.
Therefore, the metabolic clearance is much lower in patients with end-stage renal failure than in healthy subjects.
Zato je presnovni očistek mnogo nižji pri pacientih s končno odpovedjo ledvic kot pri zdravih osebah.
There have been no reports that other drugs influence the effects of FORCALTONIN.
Vpliv drugih zdravil na učinek FORCALTONINa ni znan.
calcitonin, peak plasma concentration lies between about 200 and 400 pg/ml.
Po parenteralnem dajanju 100 IE kalcitonina je maksimalna koncentracija v plazmi med 200 in 400 pg/ml.
Do not use after the expiry date stated on the ampoule and the packaging.
Zdravila ne smete uporabljati po izteku roka uporabnosti, ki je naveden na ampuli in na škatli.
174 56 Alimos, Athens, Greece.
7, P. Marinopoulou Str. 174 56 Alimos, Atene, Grčija
OTHER SPECIAL WARNING(S), IF NECESSARY
DRUGA POSEBNA OPOZORILA, ČE SO POTREBNA NE ZAMRZUJTE.
Important Information about some of the Ingredients of FORCALTONIN This medicinal product contains less than 1 mmole (23 mg) sodium per dose, i.e. essentially sodium free.
Pomembni podatki o nekaterih sestavinah FORCALTONINA To zdravilo vsebuje manj kot 1 mmol (23 mg) soli na dozo, t.j.
The effects of recombinant salmon calcitonin on the body have also been shown to be equivalent to those of synthetic salmon calcitonin.
Pokazalo se je, da so učinki rekombinantnega lososovega kalcitonina na telo enakovredni učinkom sintetično pridobljenega lososovega kalcitonina.
A minimum dose of 50 International Units (7.5 micrograms of salmon calcitonin) three times a week in some patients may be sufficient.
Pri nekaterih bolnikih lahko zadošča najnižji odmerek 50 mednarodnih enot (7,5 mikrograma lososovega kalcitonina) trikrat na teden.
Unigene UK Limited 191 Sparrows Herne Bushey Heath Hertfordshire WD23 1AJ United Kingdom
Unigene UK Limited 191 Sparrows Herne Bushey Heath Hertfordshire WD23 1AJ Velika Britanija
Skin testing should be conducted in patients with suspected sensitivity to calcitonin prior to their treatment with calcitonin.
Pri bolnikih, za katere sumimo, da so občutljivi na kalcitonin, je treba pred začetkom uporabe zdravila opraviti kožno testiranje.
Salmon calcitonin does not cross the placental barrier.
Lososov kalcitonin ne prehaja skozi placento.
Keep out of the reach and sight of children
Zdravilo shranjujte zunaj dosega in pogleda otrok.
MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS {NATURE/TYPE}
PODATKI, KI MORAJO BITI NAVEDENI NA MANJŠIH STIČNIH OVOJNINAH {VRSTA/TIP}
The following instructions for use are recommended to ensure that you obtain the full benefit of treatment with FORCALTONIN.
Priporočamo vam, da upoštevate to navodilo za uporabo, da vam bo FORCALTONIN kar najbolj koristil.
The calcium-lowering effect of calcitonin is caused both by a decrease in the efflux of calcium from the bone to the ECF and inhibition of renal tubular reabsorption of calcium.
Kalcitoninov učinek na zniževanje kalcija povzročata zmanjšano prehajanje kalcija iz kosti v ECT in tudi inhibicija ledvične tubulne reabsorpcije kalcija.
Forcaltonin is contained in Type I, glass ampoules, designed to accommodate up to 1 ml of solution.
Forcaltonin je na voljo v steklenih ampulah iz stekla vrste I oblike B, ki vsebujejo do 1 ml raztopine.
Calcitonin is a calciotropic hormone, which inhibits bone resorption by a direct action on osteoclasts.
Kalcitonin je kalciotropen hormon, ki zavira resorpcijo kosti z neposrednim delovanjem na osteoklaste.
Do not use Forcaltonin if you notice the solution is not completely clear and colourless.
Forcaltonina ne smete uporabiti, če raztopina ni prozorna in brezbarvna.
The effect is more evident on initiation of therapy and tends to decrease or disappear with continued administration or a reduction in dose.
Ta učinek je bolj viden na začetku in se ponavadi zmanjša ali izgine med nadaljevanjem zdravljenja ali z zmanjšanjem odmerka.
Skin and subcutaneous tissue disorders Uncommon: skin rash
Bolezni kože in podkožja Občasni: kožni izpuščaj
• Paget's disease
Pagetova bolezen
In animals, salmon calcitonin has been shown to decrease lactation and to be excreted in milk (see 5.3).
Pri živalih se je pokazalo, da lososov kalcitonin zmanjšuje laktacijo in prehaja v materino mleko (glejte poglavje 5.3), zato dojenje med zdravljenjem odsvetujemo.
The absence of mineralisation defect with calcitonin has been demonstrated by bone histomorphometric studies both in man and in animals.
S histomorfometričnimi študijami so dokazali odsotnost napak v mineralizaciji tako pri ljudeh kot pri živalih.
FORCALTONIN is a solution for injection.
FORCALTONIN je raztopina za injiciranje.
In pharmacological studies, calcitonin has been shown to have analgesic activity in animal models.
Farmakološke študije so pokazale, da je imel kalcitonin na živalskih modelih protibolečinski učinek.
Metabolic and nutrition disorders:
Presnovne in prehranske motnje
• diarrhoea
• diareja,
Like all medicines, FORCALTONIN can have side effects.
Kot vsa zdravila ima lahko tudi FORCALTONIN neželene učinke.
PHARMACEUTICAL FORM Solution for injection Clear colourless solution
FARMACEVTSKA OBLIKA Raztopina za injiciranje Prozorna brezbarvna raztopina
PHARMACEUTICAL FORM AND CONTENTS Solution for injection - Pack of 10 doses:
Raztopina za injiciranje - škatla z 10 odmerki:
Peak plasma concentrations are attained within the first hour of administration.
Maksimalna koncentracija v plazmi se doseže prvo uro po dajanju zdravila.
METHOD AND ROUTE(S) OF ADMINISTRATION For subcutaneous (SC), intramuscular (IM) or intravenous (IV) injection.
POSTOPEK IN POT(I) UPORABE ZDRAVILA Za subkutano (s.c.), intramuskularno (i.m.)
In severe or emergency cases, intravenous infusion with up to 10 IU/kg body weight in 500ml 0.9% w/v sodium chloride solution may be administered over a period of at least 6 hours.
V hudih ali nujnih primerih smemo dati bolniku intravensko infuzijo z do 10 IE/kg telesne mase v 500 ml natrijevega klorida 9 mg/ml (0,9 %) raztopine za injiciranje, v trajanju najmanj 6 ur.
Driving and using machines:
Vpliv na sposobnost upravljanja vozil in strojev:
The recommended dose is 100 International Units (15 micrograms of salmon calcitonin) daily, or 50 International Units (7.5 micrograms salmon calcitonin) twice daily, for 2 to 4 weeks, by subcutaneous or intramuscular injection.
Priporočeni odmerek je 100 mednarodnih enot (15 mikrogramov lososovega kalcitonina) na dan ali 50 mednarodnih enot (7,5 mikrograma lososovega kalcitonina) dvakrat na dan za 2 do 4 tedne, s subkutanim ali intramuskularnim injiciranjem.
Serum calcium levels may be transiently decreased to below normal levels following administration of calcitonin, notably upon initiation of therapy in patients with abnormally high rates of bone turnover.
Serumska raven kalcija lahko po tem, ko bolnik dobi kalcitonin, zlasti še na začetku zdravljenja pri bolnikih z nenormalno visoko stopnjo kostne presnove, začasno pade pod normalno raven.
This medicinal product contains less than 1 mmol sodium (23 mg) per dose, i.e. it is essentially sodium free.
To zdravilo vsebuje manj kot 1 mmol soli (23 mg) na dozo, t.j.
Read the package leaflet before use.
Pred uporabo preberite navodila v škatli.
Calcitonin has not been studied in pregnant women.
Vpliva kalcitonina med nosečnostjo niso preučevali.
The recommended dose is 100 International Units (15 micrograms of salmon calcitonin) once daily by subcutaneous or intramuscular injection.
Priporočeni odmerek je 100 mednarodnih enot (15 mikrogramov lososovega kalcitonina) enkrat dnevno, s subkutanim ali intramuskularnim injiciranjem.
of injectable salmon calcitonin have been administered without adverse reactions, other than nausea and vomiting, and exacerbation of pharmacological effects.
Posamezni odmerki (do 10.000 IE) lososovega kalcitonina za injiciranje so bili dani brez neželenih učinkov, razen slabosti in bruhanja ter poslabšanja farmakološkega učinka.
In severe or emergency cases, an intravenous infusion with 10 International Units per kilogram body weight in 500 ml 0.9% w/v sodium chloride solution may be given to you by your doctor or nurse over a period of 6 hours.
V hudih ali nujnih primerih vam lahko zdravnik ali medicinska sestra da intravensko infuzijo z 10 mednarodnimi enotami na kg telesne mase, v 500 ml natrijevega klorida 9 mg/ml (0,9 %) raztopine za injiciranje, v trajanju 6 ur.
Keep this leaflet.
Ne zamrzujte.
Any unused product must be discarded.
Neporabljena zdravila zavrzite.
Acetic acid, glacial, sodium acetate trihydrate, sodium chloride and water for injections.
Ocetna kislina, ledocet, natrijev actetat trihidrat, natrijev klorid in voda za injekcije.
Never take a double dose to make up for a missed dose.
Ne vzemite dvojnega odmerka, če ste pozabili vzeti prejšnjega.
The Marketing Authorisation Holder for FORCALTONIN is Unigene UK Limited, 191 Sparrows Herne, Bushey Heath, Hertfordshire WD23 1AJ, UK.
Imetnik dovoljenja za promet z zdravilom FORCALTONIN je Unigene UK Limited, 191 Sparrows Herne, Bushey Heath, Hertfordshire WD23 1AJ, Velika Britanija.
Each ampoule contains 100 IU (15 micrograms in 1.0 ml) of recombinant salmon calcitonin.
Vsaka ampula vsebuje 100 IE (15 mikrogramov v 1,0 ml) rekombinantnega lososovega kalcitonina.
After first opening, the product should be used immediately.
Zdravilo je treba uporabiti takoj, ko ste ga odprli.
The recommended starting dose is 100 International Units (15 micrograms of salmon calcitonin) every 6 to 8 hours by subcutaneous or intramuscular injection.
Priporočeni začetni odmerek je 100 mednarodnih enot (15 mikrogramov lososovega kalcitonina) vsakih 6 do 8 ur, s subkutanim ali intramuskularnim injiciranjem.
MARKETING AUTHORISATION HOLDER Unigene UK Limited, 191 Sparrows Herne, Bushey Heath, Hertfordshire WD23 1AJ, UK
IMETNIK DOVOLJENJA ZA PROMET Unigene UK Limited, 191 Sparrows Herne, Bushey Heath, Hertfordshire WD23 1AJ, Velika Britanija
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION FORCALTONIN 100 IU solution for injection
IME ZDRAVILA IN POT(I) UPORABE FORCALTONIN 100 IE raztopina za injiciranje
An increased incidence of pituitary adenomas has been reported in rats given synthetic salmon calcitonin for 1 year.
Pri podganah, ki so 1 leto prejemale sintetični lososov kalcitonin, so poročali o povečani pogostnosti adenoma hipofize.
Inform your doctor immediately if any of the above effects occur.
Če pride do zgoraj opisanih učinkov, takoj obvestite svojega zdravnika, ki bo ustrezno ukrepal.
Most of the effects do not last long and disappear of their own accord.
Večina teh učinkov ne traja dolgo in izgine sama od sebe. Preostale učinke, če ne izginejo, lahko zdravi vaš zdravnik.
If you are unsure whether you are allergic to salmon calcitonin, please discuss the matter with your doctor.
Če niste prepričani, ali ste alergični na lososov kalcitonin ali ne, se o tem pogovorite s svojim zdravnikom, ki lahko opravi kožno testiranje, s katerim ugotovi, kako občutljivi ste na lososov kalcitonin.
If you have any questions about your treatment schedule, ask your doctor or nurse.
O vsem, kar želite vedeti v zvezi z načrtom svojega zdravljenja, vprašajte zdravnika ali medicinsko sestro.
NAME OF THE MEDICINAL PRODUCT Forcaltonin 100 IU solution for injection
IME ZDRAVILA Forcaltonin 100 IE raztopina za injiciranje
• dizziness
• omotičnost.
The active substance of FORCALTONIN is recombinant salmon calcitonin.
Zdravilna učinkovina v zdravilu FORCALTONIN je rekombinantni lososov kalcitonin.
Injectable calcitonin may cause transient dizziness (see 4.8.
Kalcitonin za injiciranje lahko začasno povzroča omotičnost (glejte poglavje 4.8 Neželeni učinki), ki lahko poslabša odzivnost bolnika.
The other ingredients are acetic acid, glacial, sodium acetate trihydrate, sodium chloride and water for injections.
Pomožne snovi so ocetna kislina, ledocet, natrijev actetat trihidrat, natrijev klorid in voda za injekcije.
METHOD OF ADMINISTRATION Read the package leaflet before use.
POSTOPEK UPORABE Pred uporabo preberite navodila v škatli.
The treatment should be maintained until patients are fully mobilized.
Odmerek lahko na začetku remobilizacije zmanjšamo na 50 IE na dan. Z uporabo zdravila je treba nadaljevati, dokler ni bolnik znova popolnoma mobiliziran.
LIST OF EXCIPIENTS Excipients: Acetic acid, glacial, sodium acetate trihydrate, sodium chloride and water for injections.
SEZNAM POMOŽNIH SNOVI Pomožne snovi: ocetna kislina, ledocet, natrijev actetat trihidrat, natrijev klorid in voda za injekcije.
FORCALTONIN must be given by injection.
FORCALTONIN dajemo bolnikom samo z injiciranjem.
Do not pass it on to anyone else.
Zdravilo predpiše samo vam in ga ne smete dati drugim.
Your doctor may reduce the dose of FORCALTONIN after your condition has improved.
Ko se vam stanje izboljša, vam zdravnik odmerek FORCALTONINa lahko zmanjša.
BEFORE YOU USE FORCALTONIN
KAJ MORATE VEDETI, PREDEN BOSTE UPORABILI FORCALTONIN
It is recommended that you do not inject your medicine at exactly the same site each time you use it in order to avoid discomfort.
Da bi se izognili tej neprijetnosti, svetujemo, da zdravila ne injicirate vedno na istem mestu.
FORCALTONIN 100 IU Solution for Injection, recombinant salmon calcitonin
FORCALTONIN 100 IE raztopina za injiciranje rekombinantni lososov kalcitonin
The active substance is recombinant salmon calcitonin.
Zdravilna učinkovina je rekombinantni lososov kalcitonin.
Hypercalcaemia of malignancy.
Hiperkalciemija zaradi malignih obolenj.
twice daily for 2 to 4 weeks, administered subcutaneously or intramuscularly.
Priporočeni odmerek je 100 IE na dan ali 50 IE dvakrat na dan, 2 do 4 tedne, dan subkutano ali intramuskularno.
Each ampoule of FORCALTONIN contains 1 ml of solution with 100 International Units (IU) of the active substance.
Vsaka ampula zdravila FORCALTONIN vsebuje 1 ml raztopine s 100 mednarodnimi enotami (IE) zdravilne učinkovine, ki ustreza približno 15 mikrogramom rekombinantnega lososovega kalcitonina.
Renal and urinary disorders: Uncommon: diuresis
Bolezni sečil Občasni: diureza
However, the clinical relevance of this finding is not known (see section 5.2)
Presnovni očistek je dosti nižji pri bolnikih s končno odpovedjo ledvic kot pri zdravih osebah, vendar klinična pomembnost te ugotovitve ni znana (glejte poglavje 5.2).
FORCALTONIN should therefore not be given to pregnant women.
Varnost uporabe med nosečnostjo ni znana, zato ni priporočljivo dajati FORCALTONIN nosečnicam.
Irritation at or around the injection site has been reported occasionally in patients treated with salmon calcitonin.
Pri bolnikih, zdravljenih z lososovim kalcitoninom, so poročali o občasnem vnetju kože na mestu injiciranja ali okoli njega.
Immune system disorders:
Bolezni imunskega sistema
Skin flushes (facial or upper body).
Zelo pogosti: rdečica (na obrazu ali zgornjem delu telesa).
General characteristics of the active substance
Splošne lastnosti zdravilne učinkovine
Tell your doctor or nurse immediately, if you notice any of the effects listed below.
Če opazite katerega od spodaj navedenih učinkov, nemudoma obvestite svojega zdravnika ali medicinsko sestro.
Tell your doctor as soon as possible if you miss a dose of FORCALTONIN.
Če pozabite vzeti odmerek FORCALTONINa, o tem čim prej obvestite zdravnika.
• skin rash
• kožni izpuščaj,
Hypercalcemia of malignancy:
Hiperkalciemija zaradi malignih obolenj
• Hypercalcaemia of malignancy
• pri hiperkalciemiji zaradi malignih obolenj.
The product should be inspected visually for particulate matter and discoloration prior to administration.
Zdravilo pred uporabo preglejte, ali so v njem vidni trdni delci in ali je prisotno razbarvanje.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OR, WHERE THERE IS NO OUTER PACKAGING, ON THE IMMEDIATE PACKAGING
PODATKI NA ZUNANJI OVOJNINI ALI STIČNI OZ. PRIMARNI OVOJNINI, KADAR ZUNANJE NI
PACKAGE LEAFLET
Bolezni prebavil
List of the names, pharmaceutical form, strength of the medicinal products, route of administration, applicants/ marketing authorisation holders in the Member States
Seznam imen, farmacevtskih oblik, jakosti zdravila, poti uporabe, predlagateljev, imetnikov dovoljenj za promet z zdravilom v državah članicah
ATC code: N05A H03.
Oznaka ATC: N05A H03.
Your doctor will tell you how many Olanzapine Teva tablets to take and how long you should continue to take them.
Zdravnik vam bo povedal, koliko Olanzapin Teva tablet morate vzeti in kako dolgo naj bi jih jemali.
4042 Debrecen Hungary
4042 Debrecen Madžarska
Teva Pharmaceutical Works Co. Ltd Pallagi út 13, 4042 Debrecen Hungary
Teva Pharmaceutical Works Co. Ltd Pallagi út 13, 4042 Debrecen Madžarska
Parkinson's disease
• Parkinsonovo bolezen
Tell your doctor or pharmacist if you are taking, have recently taken or might take use any other medicines.
Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo.
Do not use this medicine after the expiry date which is stated on the carton after EXP.
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli poleg oznake “EXP”.
- Medicines of this type may cause unusual movements mainly of the face or tongue.
- Tovrstna zdravila lahko povzročijo nenavadne zgibke predvsem v mišicah obraza ali jezika.
The mean increase in olanzapine AUC was 52% and 108% respectively.
Srednje povečanje AUC olanzapina je bilo 52 % oziroma 108 %.
If this happens after you have been given Olanzapine Teva tell your doctor.
Če se vam to zgodi po tem, ko ste prejeli zdravilo Olanzapin Teva, povejte svojemu zdravniku.
Orodispersible tablet is the technical name for a tablet which dissolves directly in your mouth, so that it can be easily swallowed.
Orodisperzibilna tableta je tehnično ime za tableto, ki se raztopi neposredno v ustih, tako da jo zlahka pogoltnete.
This leaflet was last revised in <{MM/YYYY}><{month YYYY}>.
Navodilo je bilo nazadnje revidirano dne <{MM/LLLL}><{mesec LLLL}.>
With long-term exposure (at least 24 weeks), 89.4% gained ≥7%,
Pri dolgoročni izpostavljenosti (najmanj 24 tednov) jih je 89,4 % pridobilo ≥ 7 %,